Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Double-blind Phase	STARTED	LAI 590 mg QD	44
Double-blind Phase	STARTED	Placebo	45
Double-blind Phase	COMPLETED	LAI 590 mg QD	40
Double-blind Phase	COMPLETED	Placebo	45
Double-blind Phase	NOT COMPLETED	LAI 590 mg QD	4
Double-blind Phase	NOT COMPLETED	Placebo	0
Open-label Phase	STARTED	LAI 590 mg QD	35
Open-label Phase	STARTED	Placebo	43
Open-label Phase	COMPLETED	LAI 590 mg QD	34
Open-label Phase	COMPLETED	Placebo	41
Open-label Phase	NOT COMPLETED	LAI 590 mg QD	1
Open-label Phase	NOT COMPLETED	Placebo	2
12-Month Follow-up Period	STARTED	LAI 590 mg QD	27
12-Month Follow-up Period	STARTED	Placebo	32
12-Month Follow-up Period	COMPLETED	LAI 590 mg QD	26
12-Month Follow-up Period	COMPLETED	Placebo	31
12-Month Follow-up Period	NOT COMPLETED	LAI 590 mg QD	1
12-Month Follow-up Period	NOT COMPLETED	Placebo	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01315236/flow